Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1514 studies found for:    "Embolism and Thrombosis"
Show Display Options
Rank Status Study
1 Completed The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
Condition: Embolism and Thrombosis
Interventions: Drug: Dalteparin;   Drug: Warfarin
2 Recruiting Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Condition: Pulmonary Embolism and Thrombosis
Intervention: Device: EkosSonic Endovascular System plus thrombolytic
3 Recruiting Radial Artery Occlusion After Endovascular Procedure
Condition: Embolism and Thrombosis of the Radial Artery
Intervention: Drug: heparin
4 Completed Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants
Conditions: Embolism and Thrombosis;   Hemorrhage
Intervention: Biological: Blood samples for DOAC measurement
5 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
6 Recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
7 Enrolling by invitation Comparison of Accidents and Their Circumstances With Oral Anticoagulants
Conditions: Cardiovascular Complications;   Hemorrhagic Disorders;   Embolism and Thrombosis
Intervention: Other: Follow up
8 Recruiting Medical Assistance for the Procreation and Risk of Thrombosis.
Conditions: Ovarian Hyperstimulation Syndrome;   Cardiovascular Diseases;   Embolism and Thrombosis
Intervention: Other: ovarian stimulation
9 Completed
Has Results
Registry of AngioJet Use in the Peripheral Vascular System
Conditions: Peripheral Vascular Disease;   Embolism and Thrombosis;   Venous Thrombosis
Intervention:
10 Completed Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
Conditions: Venous Thromboembolism;   Embolism and Thrombosis;   Hip Fractures
Intervention: Drug: TTP889
11 Completed Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Conditions: Blood Disease;   Anemia, Sickle Cell;   Cerebrovascular Disorders;   Cerebral Embolism and Thrombosis
Intervention:
12 Completed Stroke Prevention in Sickle Cell Anemia (STOP 1)
Conditions: Anemia, Sickle Cell;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Hematologic Diseases;   Hemoglobinopathies
Intervention: Procedure: blood transfusion
13 Completed
Has Results
Epidemiology of Thromboembolism Disease: A Cohort Study
Conditions: Vascular Diseases;   Embolism and Thrombosis;   Phlebitis;   Venous Insufficiency;   Pulmonary Embolism
Intervention: Other: procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis
14 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
15 Completed
Has Results
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Embolism and Thrombosis;   Deep Vein Thrombosis;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176b 15mg;   Drug: DU-176b 30mg;   Drug: Enoxaparin sodium 20 mg (=2000IU)
16 Active, not recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
17 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Conditions: Embolism and Thrombosis;   Embolism;   Vascular Diseases;   Warfarin;   Venous Thromboembolism;   Thrombosis;   Thromboembolism
Intervention: Other: CYP 2C9 and VKORC1 Testing for Warfarin
18 Completed Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Conditions: Arrhythmia;   Atrial Fibrillation;   Cardiovascular Diseases;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Heart Diseases;   Thrombophlebitis;   Cerebrovascular Accident
Intervention: Drug: warfarin
19 Completed Ex Vivo Human Thrombosis Chamber Study
Condition: Cardiovascular Disease
Interventions: Drug: Clopidogrel;   Drug: Aspirin
20 Completed Efficacy and Safety of Natto Extract
Conditions: Thrombosis;   Cardiovascular Diseases
Intervention: Drug: Natto extract (Nattokinase)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.